ロード中...
Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
Glycoprotein IIb/IIIa antagonists are well established for their effectiveness in improving clinical outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention. Acute profound thrombocytopenia is a rare complication of abciximab. We present a case which was managed su...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Society of Cardiology
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3772301/ https://ncbi.nlm.nih.gov/pubmed/24044015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4070/kcj.2013.43.8.557 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|